317 related articles for article (PubMed ID: 12213582)
21. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
22. NF-kappaB in solid tumors.
Pacifico F; Leonardi A
Biochem Pharmacol; 2006 Oct; 72(9):1142-52. PubMed ID: 16956585
[TBL] [Abstract][Full Text] [Related]
23. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.
Lin Y; Bai L; Chen W; Xu S
Expert Opin Ther Targets; 2010 Jan; 14(1):45-55. PubMed ID: 20001209
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
25. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target.
Chen W; Li Z; Bai L; Lin Y
Front Biosci (Landmark Ed); 2011 Jan; 16(3):1172-85. PubMed ID: 21196225
[TBL] [Abstract][Full Text] [Related]
26. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
28. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.
Holcomb B; Yip-Schneider M; Schmidt CM
Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834
[TBL] [Abstract][Full Text] [Related]
29. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
30. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis.
Sethi G; Ahn KS; Aggarwal BB
Mol Cancer Res; 2008 Jun; 6(6):1059-70. PubMed ID: 18567808
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-kappaB: a friend or a foe in cancer?
Shishodia S; Aggarwal BB
Biochem Pharmacol; 2004 Sep; 68(6):1071-80. PubMed ID: 15313403
[TBL] [Abstract][Full Text] [Related]
32. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression.
Shishodia S; Aggarwal BB
Oncogene; 2006 Mar; 25(10):1463-73. PubMed ID: 16331273
[TBL] [Abstract][Full Text] [Related]
33. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
35. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Bindhu OS; Ramadas K; Sebastian P; Pillai MR
Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875
[TBL] [Abstract][Full Text] [Related]
36. Antinflammatory and anticancer effects of terpenes from oily fractions of Teucruim alopecurus, blocker of IκBα kinase, through downregulation of NF-κB activation, potentiation of apoptosis and suppression of NF-κB-regulated gene expression.
Guesmi F; Prasad S; Tyagi AK; Landoulsi A
Biomed Pharmacother; 2017 Nov; 95():1876-1885. PubMed ID: 28968948
[TBL] [Abstract][Full Text] [Related]
37. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.
Aggarwal BB; Vijayalekshmi RV; Sung B
Clin Cancer Res; 2009 Jan; 15(2):425-30. PubMed ID: 19147746
[TBL] [Abstract][Full Text] [Related]
38. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer.
Prasad S; Phromnoi K; Yadav VR; Chaturvedi MM; Aggarwal BB
Planta Med; 2010 Aug; 76(11):1044-63. PubMed ID: 20635307
[TBL] [Abstract][Full Text] [Related]
39. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
40. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]